Carcinoidsyndrome refers to the array of symptoms that occur secondary to carcinoidtumors.
Carcinoidtumors produce the vasoactive substance, serotonin; it is commonly but incorrectly thought that serotonin is the cause of the flushing.
Carcinoidtumors arising in the bronchi, because their biologically active products reach the systemic circulation before passing through the liver, may be associated with manifestations of carcinoidsyndrome without liver metastases.
Carcinoid Syndrome Epidemiology and Pathophysiology(Site not responding. Last check: 2007-11-03)
Carcinoidsyndrome does not usually develop until a tumor has metastasized — usually to the liver —; and the hormonal products released by the tumor reach the circulation in substantial concentrations (5, 6).
The likelihood of occurrence and the associated severity of carcinoidsyndrome depend on several factors: tumor size, whether its location is in an area draining into the systemic circulation, and the degree of metastasis (6).
Carcinoidsyndrome exhibits slow growth with early ill-defined symptoms and is frequently misdiagnosed as "irritable bowel syndrome" or "spastic colon" (1).
Among carcinoidtumors, approximately 10 percent of those in the small intestine, less than one percent of those in the appendix, and virtually none in the rectum are associated with the syndrome.
Episodic flushing is the clinical hallmark of the carcinoidsyndrome, and occurs in 85 percent of patients.
Surgical procedures in patients with carcinoidsyndrome are potentially hazardous due to the precipitation of carcinoid crisis during induction of anesthesia or surgical manipulation of tumors.
Malignant carcinoidsyndrome is not a cause of sustained hypertension, and a rise in blood pressure during flushing is rare.
Carcinoid heart disease is reported in approximately 50-60% of all patients with malignant carcinoidsyndrome and is severe in approximately 25%.
The primary carcinoids of the bowel usually are not observed on CT scanning; otherwise, this study allows the assessment of the extent of tumor spread to the mesentery and bowel wall and metastases to the lymph nodes and liver.
Carcinoids of the lung (bronchial carcinoid) are often associated with their own special peculiarities, diagnostic modalities and forms of treatment.
Not all functioning carcinoidtumors produce the same large variety of chemicals and hormones and it is not yet entirely clear as to which of the substances are responsible for each of the symptoms of the CarcinoidSyndrome.
The CarcinoidSyndrome, due to the presence of a functioning carcinoidtumor, is easily diagnosed when all the features of the syndrome are present or even when 1 or 2 of the main symptoms are present and the CarcinoidSyndrome is thought of.
Carcinoidsyndrome is caused by an uncommon intestinal or lung tumor, called a carcinoidtumor, that secretes excess quantities of hormones.
Symptoms associated with carcinoidtumors (also called argentaffinomas) include attacks of severe flushing of the skin lasting from minutes to days, watery diarrhea, abdominal cramps, bronchoconstrictive attacks, and edema (swelling) of the head and neck.
Metastatic carcinoidtumors may be diagnosed by the clinical findings and by elevated levels of 24-hour urinary 5-hydroxyindolacetic acid (5-HIAA), a metabolic product of the serotonin produced by the tumor.
NETumoradvisor | Carcinoid Tumors | Symptoms: Carcinoid Syndrome(Site not responding. Last check: 2007-11-03)
Carcinoidsyndrome is a collection of symptoms that is present in about 8% of all patients with carcinoidtumors.
Carcinoidsyndrome usually only occurs when tumor cells spread to the liver and release serotonin directly into the circulation before they can be inactivated by normal liver cells.
Carcinoid crisis can occur spontaneously when anesthesia is given for surgical procedures, or as a result of stress, chemotherapy, or infection.
Carcinoidtumors, or carcinoids, originate in hormone-producing cells of the gastrointestinal (GI) tract (i.e., esophagus, stomach, small intestine, colon), the respiratory tract (i.e., lungs, trachea, bronchi), the hepatobiliary system (i.e., pancreas, gallbladder, liver), and the reproductive glands (i.e., testes, ovaries).
Carcinoidtumors of the appendix usually are benign and often occur between the ages of 20 and 40.
Carcinoidtumors that are confined to the GI tract may not cause symptoms (i.e., be asymptomatic) because the hormones produced by these tumors are released into the bloodstream and destroyed by the liver.
Carcinoid Tumor -- eCureMe.com(Site not responding. Last check: 2007-11-03)
In a few cases of bronchial carcinoidtumors, the cancer is located in the very outer part of the lungs and may not cause any symptoms at all.
Carcinoidtumors that develop in the appendix or rectum are usually very slow growing and rarely affect long-term survival.
For carcinoids that develop in other parts of the intestine or stomach, the 5-year survival is 95% if it has not spread, 65% if it has only spread to the local lymph nodes, and about 20% if it has metastasized to the liver.
Carcinoid Tumors: Hormonal Disorders: Merck Manual Home Edition(Site not responding. Last check: 2007-11-03)
Carcinoidtumors are noncancerous (benign) or cancerous (malignant) growths that produce excessive amounts of hormonelike substances.
When carcinoidtumors occur in the digestive tract or pancreas, the substances they produce are released into a blood vessel that flows directly to the liver (portal vein), where enzymes destroy them.
Carcinoidtumors of the lungs, testes, and ovaries also cause symptoms because the substances they produce bypass the liver and circulate widely in the bloodstream.
Carcinoidsyndrome occurs when a rare cancerous tumor called a carcinoidtumor secretes serotonin and other chemicals into your bloodstream, causing a variety of signs and symptoms.
Carcinoidtumors in the intestine, on the other hand, secrete their chemicals into blood that must first pass through the liver before reaching the rest of the body.
Carcinoid Syndrome Treatment(Site not responding. Last check: 2007-11-03)
The treatment of carcinoidsyndrome requires peripheral treatments that address its various symptoms: diuretics for heart disease, bronchodilators for wheezing, as well as targeted treatments - such as somatostatin analogues — that work at the site of carcinoidtumors to inhibit hormone secretion and relieve diarrhea and flushing (1, 2, 3).
A two-sided approach to the treatment of carcinoidtumors focuses first on treatment of the tumor, and second on treatment of the syndrome (3).
It is effective in VIPoma/watery diarrheasyndrome for a majority of patients in whom diarrhea and hypokalemia are resistant to other modes of therapy (3).
CarcinoidSyndrome is a rare, malignant disease affecting the small bowel, stomach and/or pancreas.
The syndrome may also be accompanied by stomach pain, blockage of arteries in the liver, heart palpitations and excessive peptide excretion in the urine.
If the original carcinoid cells spread (metastasize) to the liver, larger than normal amounts of these peptides are released into the circulation causing the signs and symptoms of CarcinoidSyndrome to appear.
Carcinoidsyndrome typically causes scarring and stiffness of the tricuspid and pulmonic valves of the right side of the heart.
Typical symptoms of heart failure include an enlarged liver (due to the backup of blood returning to the failing heart which is unable to pump all of the blood returning to it), swelling of the feet and ankles (edema), and swelling of the abdomen due to fluid accumulation (ascites).
As with other cancers, scientists have recognized some changes in the DNA of carcinoidtumor cells that are probably responsible for their increased growth and abnormal spread.
PET scanning for carcinoidtumors uses a radioactive form of 5-hydroxytryptophan, a chemical that is taken up and used by carcinoid cells.
The treatment and prognosis (the outlook for chances of survival) for a patient with a gastrointestinal carcinoidtumor depends, to a large extent, on the tumor's stage.
Carcinoidsyndrome: A syndrome due to carcinoidtumor which secretes large amounts of the hormoneserotonin.
The tumor usually arises in the gastrointestinal tract, anywhere between the stomach and the rectum (the favorite spot is in the appendix) and from there may metastasize (spread) to the liver.
Syndrome: A set of signs and symptoms that tend to occur together and which reflect the presence of a particular disease or an increased chance of developing a particular disease.
NETumoradvisor | Carcinoid Tumors | Symptoms(Site not responding. Last check: 2007-11-03)
Because carcinoidtumors are generally slow-growing, they often don't produce symptoms until the tumor has spread (or "metastasized") to the liver or other organs.
Often carcinoidtumors are found by accident, during surgery or tests (such as magnetic resonance imaging, or MRI) for other conditions.
Carcinoids in the lung may secrete hormones that cause the symptoms of corticosteroid or growth hormone excess.
Carcinoidsyndrome is a group of symptoms associated with carcinoidtumor (see bronchial adenoma).
Carcinoidsyndrome is the pattern of symptoms exhibited by people with carcinoidtumors.
Normally, an amino acid called tryptophan is used by the body to manufacture niacin and certain proteins, but in carcinoidsyndrome, it gets diverted to form serotonin.
Carcinoidsyndrome is a disease consisting of a combination of symptoms, physical manifestations, and abnormal laboratory chemical findings caused by a carcinoidtumor.
Carcinoid tumours, the most common type of gastro-entero-pancreatic neuroendocrine (GEP NE) tumour, tend to yield vague symptoms, and are often misdiagnosed as other disorders, such as irritable bowel syndrome.
For carcinoid tumours of the cervix, for example, the average age of onset is 39 years; of the small intestine, 63 years; and of the rectum, 66 years.
Significantly elevated levels of serotonin or its metabolites, especially increased urinary excretion of 5-hydroxyindoleacetic acid (5-HIAA), are observed in patients with carcinoidsyndrome.
Carcinoid syndrome. DermNet NZ(Site not responding. Last check: 2007-11-03)
Carcinoidsyndrome is a group of symptoms and signs associated with carcinoid tumours.
The main cutaneous feature of carcinoidsyndrome is flushing, which occurs in 75% of cases.
Patients with carcinoidsyndrome need to undergo thorough medical and physical examinations, and appropriate blood tests and X-rays to follow the growth and activity of the carcinoid tumour(s).